Heterocyclic antagonists of prostaglandin D2 receptors
US8383654B2 · kind B2 · utility
5Cited by
19References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2009 |
| Grant date | Feb 26, 2013 |
| Priority date | — |
| Expiry date | Jan 3, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D271/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are heteroaryl compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the heteroaryl compounds described. Also described herein are methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.